Loading clinical trials...

Trust Game and Placebo Response | Clinical Trials | Clareo Health

COMPLETEDNA

Trust Game and Placebo Response

NCT02578212•University Hospital, Basel, Switzerland

Summary

In the proposed study, investigators aim to investigate the role of interpersonal trust in the conditioned placebo analgesia process with healthy male subjects in a standardized experimental heat pain paradigm.

Eligibility

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Men: age between 18 and 40 years old
•Healthy by self-report statement, thus no known current or chronic somatic diseases or psychiatric disorders
•Right-handedness (Oldfield, 1971)
•Willing to participate in study

Exclusion Criteria

•Any acute or chronic disease (chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes) as well as skin pathologies, neuropathies or nerve entrapment symptoms, sensory abnormalities affecting the tactile or thermal modality
•Current medications (psychoactive medication, narcotics, intake of analgesics) or being currently in psychological or psychiatric treatment
•Insufficient German language skills to understand the instructions
•Previous participation in studies using pain assessment (threshold and tolerance) with Peltier Devices
•Daily consumption of more than three alcoholic standard beverages per day (a standard alcoholic beverage is defined as either 3dl beer or 1 dl wine or 2cl spirits
•Current or regular drug consumption (THC, cocaine, heroin, etc.)

Locations (1)

University of Basel

Basel, Switzerland

Key Dates

Start Date

January 1, 2015

Primary Completion Date

March 1, 2016

Completion Date

March 1, 2016

Last Updated

April 8, 2016

Enrollment

106

ACTUAL participants

Conditions

Placebo EffectPainTrust

Interventions

Placebo

OTHER

Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

NCT06346132

Virtual RealityMedical Device+2 more

View study

RECRUITINGPHASE1

A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis

NCT07351968

Moderate Pain in Knee OsteoarthritisSevere Pain in Knee Osteoarthritis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 8, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Trust Game and Placebo Response

Inclusion Criteria

Exclusion Criteria

Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis

Comparison Between Tranversus Abdominis Plane (TAP) Block With Only Bupivacaine and TAP Block With Bupivacaine Plus Ketamine in Reducing Postoperative Pain After Total Abdominal Hystrectomy

Intertransverse Process Block to Improve Quality of Recovery and Pain Management in Adult Cardiac Surgical Patients

Evaluating Postoperative Pain and Antibacterial Effect of Ultrasonic and 980 nm Diode Laser Combination

Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study